BLACKROCK ADVISORS LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 93 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$893,000
-36.6%
375,264
-2.2%
0.00%0.0%
Q3 2016$1,408,000
+48.4%
383,690
-9.8%
0.00%0.0%
Q2 2016$949,000
+7.5%
425,410
+0.2%
0.00%0.0%
Q1 2016$883,000
-29.5%
424,427
+2.7%
0.00%0.0%
Q4 2015$1,252,000
+7.5%
413,126
-12.4%
0.00%0.0%
Q3 2015$1,165,000
-16.2%
471,584
+8.9%
0.00%0.0%
Q2 2015$1,390,000
-28.9%
432,979
-21.0%
0.00%
-50.0%
Q1 2015$1,955,000
+57.8%
547,753
+0.3%
0.00%
+100.0%
Q4 2014$1,239,000
-37.8%
545,864
-46.8%
0.00%
-50.0%
Q3 2014$1,992,000
-46.0%
1,026,590
+1.1%
0.00%
-33.3%
Q2 2014$3,686,000
+136.6%
1,015,346
+152.8%
0.00%
+50.0%
Q1 2014$1,558,000
+821.9%
401,666
+578.5%
0.00%
Q4 2013$169,000
-11.1%
59,201
+11.5%
0.00%
Q3 2013$190,000
+7.3%
53,106
+0.4%
0.00%
Q2 2013$177,00052,8730.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders